In conclusion, in MS patients, we observed remarkable upregulation of antigen-specific CD8+ TEM, TEMRA and TCM, with elevated intracellular expression of granzyme B and reduced expression of PD-1 in MOG-specific CD8+ TEM. This evidence concerns the gene PDCD1 and myeloid sarcoma.